AK Medical Holdings Limited released its monthly return for the period ended 31 March 2026, confirming that authorised and issued share capital remained unchanged while share repurchase activity continued.

Authorised capital stayed at 2.00 billion ordinary shares with a par value of HKD 0.01, equivalent to HKD 20.00 million.

Issued shares were steady at 1.12 billion, and the company held no treasury shares. Management confirmed compliance with the Hong Kong Stock Exchange’s minimum public-float threshold of 25%.

Between 6 February and 26 March 2026, AK Medical repurchased 4.06 million ordinary shares that have not yet been cancelled. Once cancelled, these shares will reduce the outstanding share count.

Option activity during the month was limited to lapses: • Pre-IPO Share Option Scheme: 1.18 million options outstanding, unchanged. • Option tranche at HKD 4.66: outstanding options fell by 0.34 million to 4.50 million due to lapses. • Option tranche at HKD 10.18: 1.11 million options outstanding, unchanged. No options were exercised; therefore, no new shares were issued and no proceeds were raised.

The issuer reported no warrants, convertibles, or other share-linked instruments outstanding or issued during the month.